Birth Control After 35: When the Pill Still Fits and When to Switch

Written by William Anderson, MD

Urology

Published

Updated

Turning 35 does not automatically mean you need to stop taking birth control pills. Your health, the hormones in the product and your reasons for using it matter more than the birthday itself. A prescription that suited you years ago still deserves a review when your medical history changes.

Look beyond age. Smoking, blood pressure, migraines, clotting history and other conditions can change which contraceptive options make sense. The review should address pregnancy prevention and any menstrual symptoms that the pill helps control.

Why someone may continue the pill beyond 35

Pregnancy prevention remains a reason to use contraception during the years before menopause. Changes in bleeding patterns do not, by themselves, establish that pregnancy can no longer occur. A clinician can help you decide how long to continue protection rather than relying on an irregular period as the answer.

Doctors also prescribe birth control pills for reasons beyond contraception. Depending on the formulation and diagnosis, the treatment may help manage unpredictable periods, heavy bleeding, cramps, endometriosis symptoms or menstrual problems associated with polycystic ovary syndrome.

Describe what the medicine does for you now. Someone who takes it mainly for painful bleeding needs a plan for those symptoms if she changes methods. Someone who wants contraception without a daily task may prefer a different approach even when the current pill remains medically suitable.

Separate combined pills from progestin-only pills

Combined pills contain estrogen and a progestin. Progestin-only pills contain no estrogen. That distinction affects the safety assessment; the word "pill" does not identify a single risk profile.

Estrogen-containing contraception can raise the risk of blood clots and some cardiovascular complications. A clinician may therefore consider an estrogen-free method when a person's history makes combined contraception unsuitable. Progestin-only products have their own eligibility rules, but they do not carry the same estrogen-related clot concern.

Bring the package or the complete product name to the appointment. A recollection of the color or a previous brand may not tell the clinician which hormones you currently use. The review also needs to include other prescriptions, supplements and any changes since your last assessment.

Health changes that can alter the choice

Smoking becomes a particular concern for combined hormonal contraception at age 35 and beyond. The clinician also needs to review high blood pressure, a history of blood clots, stroke or heart disease, diabetes complications and migraines, especially migraines with aura. These conditions require individual decisions rather than a general promise that a low-dose pill will suit everyone.

A health problem can develop after years of trouble-free use. Past tolerance does not cancel a new diagnosis. Report a new blood pressure problem or clotting disorder promptly, and ask whether to change contraception while the care team investigates it.

Discuss headaches precisely. Menstrual headaches and migraine with aura do not mean the same thing, so a broad statement that the pill helps migraines can miss a safety issue. Describe visual changes, numbness, speech symptoms and any change in the pattern of your headaches.

Side effects and cancer questions need context

Nausea, breast tenderness, changes in bleeding and changes in sexual interest can affect the experience of taking a pill at any age. A symptom does not prove that contraception caused it, but a new or persistent problem deserves a review. Explain when it began and whether it follows a pattern within the pack.

Cancer research does not support a single statement that oral contraception raises or lowers every cancer risk. Observational studies associate pill use with higher breast and cervical cancer risks and lower ovarian and endometrial cancer risks. Those findings describe patterns across groups, and they do not calculate an individual's outcome.

Discuss your personal history and relevant family diagnoses with the clinician. Ask which screening you need and how the benefits of treatment compare with the concerns that apply to you. Do not interpret a relative's experience as proof that your prescription will cause the same result.

Consider how reliably the method fits daily life

A medically acceptable pill may still be a poor practical fit if you repeatedly miss doses. Work shifts, travel, refill delays or difficulty remembering a daily medicine can affect pregnancy protection. Tell the clinician about those obstacles instead of assuming you simply need more discipline.

An IUD or an implant removes the daily pill task, although insertion and removal require clinical care. Different options have different effects on bleeding, hormones and other symptoms. A method that offers less daily maintenance does not automatically replace every benefit of your current pill.

Ask for a switching plan before you stop. The timing of the change can determine whether you need temporary backup protection. Keep the instructions with the new prescription, and check what to do if you miss a dose or cannot collect the next supply on time.

What to cover at the next prescription review

Explain whether your main goal involves contraception, bleeding control, pain or several concerns. Bring an updated medication list, report smoking or nicotine use and describe new diagnoses, headaches or unusual symptoms. Ask the clinician to explain why the proposed method fits your current health rather than assuming that years of use settle the question.

Arrange follow-up when symptoms or circumstances change. A regular review gives you a chance to revisit side effects, check whether the method still suits your routine and discuss the eventual transition around menopause. Confirm how you will maintain pregnancy protection during any change in treatment.

Sources
  1. Centers for Disease Control and Prevention. U.S. Medical Eligibility Criteria for Contraceptive Use, 2024. https://www.cdc.gov/mmwr/volumes/73/rr/rr7304a1.htm
  2. National Cancer Institute. Oral Contraceptives and Cancer Risk. https://www.cancer.gov/about-cancer/causes-prevention/risk/hormones/oral-contraceptives-fact-sheet
  3. Centers for Disease Control and Prevention. Combined Hormonal Contraceptives. https://www.cdc.gov/contraception/hcp/usspr/combined-hormonal-contraceptives.html

Medical Disclaimer: This content is provided for informational and educational purposes only and does not constitute personalized medical advice, diagnosis, or treatment. Always consult a qualified physician or licensed healthcare provider with any questions regarding a medical condition or prescription medication. Read our Editorial & Medical Review Policy.